Back to Search

BRIAN DRUKER, MD

MD

Hematology & Oncology Physician

NPI: 1528073012IndividualAccepts Medicare

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

MD18379(OR)

CMS Specialties

Education

UNIVERSITY OF CALIFORNIA, SAN DIEGO SCHOOL OF MEDICINE

Class of 1981

Research & Publications (20)

Imatinib as a paradigm of targeted therapies.
PMID 15327887·Adv Cancer Res·2004
6-review
Molecularly targeted therapy: have the floodgates opened?
PMID 15266089·Oncologist·2004
6-review
Imatinib mesylate in the treatment of chronic myeloid leukaemia.
PMID 12783592·Expert Opin Pharmacother·2003
6-review
Chronic myeloid leukemia in the imatinib era.
PMID 12783367·Semin Hematol·2003
6-review
Overcoming resistance to imatinib by combining targeted agents.
PMID 12657716·Mol Cancer Ther·2003
8-other
Imatinib alone and in combination for chronic myeloid leukemia.
PMID 12563611·Semin Hematol·2003
6-review
STI571 (Gleevec) as a paradigm for cancer therapy.
PMID 11927282·Trends Mol Med·2002
6-review
Chronic myeloid leukemia. Sceptical scientists.
PMID 11784560·Lancet·2001
8-other
ST1571: a paradigm for clinical trials of molecularly targeted agents.
PMID 11769961·Biomed Pharmacother·2001
8-other
Imatinib: A Viewpoint by Brian J. Druker.
PMID 11735629·Drugs·2001
8-other
Chronic myelogenous leukemia.
PMID 11722980·Hematology Am Soc Hematol Educ Program·2001
6-review

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
3181 SW SAM JACKSON PARK RD, L952
PORTLAND, OR 97239

Quick Facts

NPI
1528073012
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
45
Publications
20

Are you this provider?

Claim Your Profile